Bradley E. Chipps
#143,154
Most Influential Person Now
Bradley E. Chipps's AcademicInfluence.com Rankings
Bradley E. Chippsphilosophy Degrees
Philosophy
#7569
World Rank
#10803
Historical Rank
Logic
#4619
World Rank
#5934
Historical Rank

Download Badge
Philosophy
Bradley E. Chipps's Degrees
- Doctorate Medicine University of California, Davis
Why Is Bradley E. Chipps Influential?
(Suggest an Edit or Addition)Bradley E. Chipps's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society. (1996) (1175)
- Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy (2015) (876)
- Oral Immunotherapy for Treatment of Egg Allergy in Children (2013) (370)
- Reduction of serum testosterone levels during chronic glucocorticoid therapy. (1986) (368)
- Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. (2004) (299)
- Long-term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma (2007) (218)
- Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. (2014) (192)
- Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. (2012) (183)
- Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. (2007) (169)
- Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. (2009) (167)
- Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema (2011) (161)
- Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. (2005) (157)
- Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study. (2019) (147)
- A randomized multicenter study evaluating Xolair persistence of response after long‐term therapy (2017) (145)
- Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. (2010) (116)
- Section on Allergy and Immunology (2011) (113)
- Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience. (2017) (112)
- Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. (2009) (112)
- Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. (2009) (109)
- Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma (2017) (109)
- Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma. (2020) (104)
- Intermittent Inhaled Corticosteroids in Infants With Episodic Wheezing (2007) (104)
- The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. (2010) (99)
- The Role of Nebulized Therapy in the Management of COPD: Evidence and Recommendations (2012) (99)
- High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. (1999) (97)
- Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma. (2016) (94)
- Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. (2006) (89)
- Gender Differences in IgE-Mediated Allergic Asthma in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) Study (2006) (87)
- The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma (2019) (83)
- Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma. (2014) (82)
- Economic burden of impairment in children with severe or difficult-to-treat asthma. (2011) (81)
- Genomewide Association Between GLCCI1 and Response to Glucocorticoid Therapy in Asthma (2012) (80)
- Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma. (2018) (80)
- A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis. (1981) (76)
- Sudden infant death syndrome in infants evaluated by apnea programs in California. (1986) (73)
- Association of Improved Air Quality With Lung Development in Children (2015) (70)
- Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay. (1973) (66)
- Clinical Tools to Assess Asthma Control in Children (2017) (65)
- Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in children. (1980) (63)
- T2-"Low" Asthma: Overview and Management Strategies. (2020) (59)
- Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies. (2017) (58)
- CONTROL OF EXPOSURE TO MITE ALLERGEN AND ALLERGEN-IMPERMEABLE BED COVERS FOR ADULTS WITH ASTHMA (2004) (56)
- Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort (2012) (53)
- Test for Respiratory and Asthma Control in Kids (TRACK): clinically meaningful changes in score. (2011) (51)
- Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma. (2009) (48)
- Improvement in quality of life with omalizumab in patients with severe allergic asthma (2006) (48)
- Noninvasive evaluation of ventricular function in cystic fibrosis. (1979) (48)
- Detection of pulmonary aspiration in infants and children with respiratory disease: concise communication. (1980) (45)
- A LONGITUDINAL, POPULATION-BASED, COHORT STUDY OF CHILDHOOD ASTHMA FOLLOWED TO ADULTHOOD (2004) (45)
- Longitudinal Validation of the Test for Respiratory and Asthma Control in Kids in Pediatric Practices (2011) (43)
- Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. (1993) (43)
- Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. (2012) (43)
- IgA deficiency, recurrent pneumonias, and bronchiectasis. (1978) (42)
- More than a decade follow‐up in patients with severe or difficult‐to‐treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II (2017) (42)
- Dose counting and the use of pressurized metered-dose inhalers: running on empty. (2006) (40)
- Cough in the pediatric population. (2010) (40)
- Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. (2009) (36)
- Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma With Self-reported Chronic Rhinosinusitis. (2020) (35)
- Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR (2010) (35)
- Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO. (2019) (35)
- High‐frequency jet ventilation in children with the adult respiratory distress syndrome complicated by pulmonary barotrauma (1993) (33)
- Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists. (2006) (32)
- Racial Disparities in Asthma-Related Health Outcomes in Children with Severe/Difficult-to-Treat Asthma. (2019) (32)
- The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma. (2018) (31)
- Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States (2011) (30)
- More Than a Decade Follow-up in Severe or Difficult-to-Treat Asthma : 1 TENOR II 2 (2017) (30)
- Allergy Testing in Childhood: Using Allergen-Specific Ige Tests (2017) (30)
- Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses (2014) (29)
- EFFECTS OF REDUCING OR DISCONTINUING INHALED BUDESONIDE IN PATIENTS WITH MILD ASTHMA (1995) (29)
- Challenges in the treatment of asthma in children and adolescents. (2018) (29)
- Nocturnal oxygen saturation in normal and asthmatic children. (1980) (28)
- Determinants of asthma and its clinical course. (2004) (28)
- Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma. (2017) (27)
- Assessment and treatment of acute asthma in children. (2005) (26)
- Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma. (2017) (25)
- Bronchial thermoplasty: a review of the evidence. (2016) (25)
- The burden of exacerbations in mild asthma: a systematic review (2020) (25)
- Effect of theophylline and terbutaline on immediate skin tests. (1980) (24)
- Dupilumab improves clinical outcomes in patients with asthma and perennial allergic rhinitis. (2020) (24)
- Update in Pediatric Anaphylaxis (2013) (23)
- Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma. (2004) (22)
- AR101 Oral Immunotherapy for Peanut Allergy (2019) (22)
- Update on the utility of corticosteroids in acute pediatric respiratory disorders (2015) (22)
- Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life. (2018) (22)
- Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO. (2017) (21)
- Pulmonary Hemangiomas of Infancy and Childhood: Report of Two Cases and Review of the Literature (2002) (21)
- Symptoms and perception of airway obstruction in asthma: clinical implications for use of reliever medications. (2019) (21)
- Benralizumab Efficacy for Patients with Fixed Airflow Obstruction and Severe, Uncontrolled Eosinophilic Asthma. (2019) (21)
- What Are the Determinates of Asthma Control? (2006) (21)
- Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma. (2012) (20)
- Severe Asthma in Primary Care: Identification and Management. (2018) (19)
- Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy (2011) (19)
- Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop. (2019) (19)
- Office-based objective measures in childhood asthma. (2006) (19)
- Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma. (2009) (19)
- Evaluation of Olopatadine Hydrochloride Nasal Spray, 0.6%, Used in Combination with an Intranasal Corticosteroid in Seasonal Allergic Rhinitis (2010) (17)
- Economic Burden of Impairment in Children with Severe or Difficult-to-Treat Asthma (2010) (17)
- Once- vs Twice-Daily Budesonide/Formoterol in 6- to 15-Year-Old Patients With Stable Asthma (2010) (17)
- The Asthma Controller Step-down Yardstick. (2019) (16)
- Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. (2022) (16)
- Continuous positive airway pressure in hemidiaphragmatic paralysis. (1980) (15)
- Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters. (2011) (15)
- Infants undergoing pyloromyotomy are not at risk for postoperative apnea (1999) (15)
- Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide. (2009) (15)
- Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure. (2020) (15)
- Non-candidal infections in children with chronic mucocutaneous candidiasis. (1979) (14)
- Evaluation of infants and children with refractory lower respiratory tract symptoms. (2010) (14)
- Immediate (IgE-mediated) skin testing in the diagnosis of allergic disease. (1978) (14)
- Efficacy and Safety of Mepolizumab in Uncontrolled Patients with Severe Eosinophilic Asthma Following a Switch from Omalizumab (OSMO Study): Exacerbation and Safety Outcomes (2018) (14)
- Associations Between Individual Characteristics and Blood Eosinophil Counts in Adults with Asthma or COPD. (2019) (14)
- Respiratory papillomas: Presentation before six months (1990) (13)
- Management of Food Allergy in the School Setting (2016) (13)
- 2020 NAEPP Guidelines Update and GINA 2021-Asthma Care Differences, Overlap, and Challenges. (2021) (12)
- Evaluating omalizumab persistency of response after long-term therapy (XPORT) (2014) (12)
- Prevention of Hereditary Angioedema Attacks With a Subcutaneous C1 Inhibitor (2017) (12)
- Systemic reaction to omalizumab. (2006) (12)
- Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics (2021) (12)
- Rapid Detection of Gram-Negative Bacteriuria by Use of the Limulus Endotoxin Assay (1973) (11)
- Asthma in infants and children. (2008) (10)
- The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results (2020) (10)
- Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II. (2020) (10)
- A Comprehensive Analysis of the Stability of Blood Eosinophil Levels (2021) (10)
- Vortran High Output Extended Aerosol Respiratory Therapy (HEART) for Delivery of Continuously Nebulized Terbutaline for the Treatment of Acute Bronchospasm (1990) (10)
- Tiotropium in Children and Adolescents With Asthma. (2019) (10)
- Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma. (2016) (10)
- Effect of Inhaled Glucocorticoids in Childhood on Adult Height (2013) (10)
- 142. The effects of oral theophylline and terbutaline on skin tests and histamine release (1978) (9)
- Antihistamine treatment for allergic rhinitis: different routes, different outcomes? (2009) (9)
- ENVIRONMENTAL EXPOSURE TO ENDOTOXIN AND ITS RELATION TO ASTHMA IN SCHOOL-AGE CHILDREN (2003) (8)
- Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaAs Needed Budesonide-Formoterol Versus Maintenance Budesonide in Mild Asthma (2018) (7)
- Severe Asthma in Children (2017) (7)
- Biologic and Maintenance Systemic Corticosteroid Therapy Among U.S., Subspecialist-treated Severe Asthma Patients. (2020) (7)
- Omalizumab significantly improves quality of life in patients with severe persistent asthma (2005) (7)
- Relative efficacy and safety of inhaled corticosteroids in patients with asthma (2020) (7)
- A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma (2001) (6)
- Clinical comparison of Gentle-Haler Actuator and Aerochamber Spacer for Metered Dose Inhaler (MDI) use by asthmatics. (1992) (6)
- Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma * Insights From the TENOR Study June (2007) (6)
- LONG TERM EFFECTS OF A LONG-ACTING B2-ADRENORECEPTOR AGONIST, SALMETEROL, ON AIRWAY HYPERRESPONSWENESS IN PATIENTS WITH MILD ASTHMA (1994) (6)
- Patient-Reported Outcomes among Omalizumab and Salmeterol/Fluticasone Combination Therapy Patients (2009) (6)
- Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic Asthma (2006) (6)
- Omalizumab in Asthma With Fixed Airway Obstruction: Post Hoc Analysis of EXTRA. (2021) (6)
- Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology. (2019) (6)
- Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study (2021) (5)
- Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma (2021) (5)
- Sequelae of H. influenzae type b empyema. (1979) (5)
- Possible Protective Effect of Omalizumab on Lung Function Decline in Patients Experiencing Asthma Exacerbations. (2020) (5)
- Test for respiratory and asthma control in kids (TRACK): a validated control tool for preschool-aged children. (2014) (5)
- Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma. (2020) (5)
- Relative efficacy and safety of inhaled corticosteroids in asthma patients: systematic review and network meta-analysis. (2020) (4)
- The Added Burden of Allergen Sensitization among Children with Severe or Poorly-Controlled Asthma. (2020) (4)
- Harmonization of Terminology for Tolerated and Reactive Dose in Food Allergy Immunotherapy. (2019) (4)
- Do weather conditions change pulmonary function of asthmatics at summer camp? (1984) (4)
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma (2018) (4)
- Assessing Construct Validity of the Asthma Impairment and Risk Questionnaire Using a 3-month Exacerbation Recall. (2022) (4)
- Diurnal variation of air and helium-oxygen flow-volume curves in asthmatic children. (1982) (4)
- Targeted IgE Therapy for Patients With Moderate to Severe Asthma. (2004) (4)
- RapidDetection ofGram-Negative Bacteriuria byUseoftheLimulus Endotoxin Assay (1973) (4)
- Budesonide Inhalation Suspension Reduces the Need for Emergency Intervention in Pediatric Asthma: A Named‐Patient Case Series (2003) (4)
- Efficacy and Safety of Mepolizumab in Uncontrolled Patients with Severe Eosinophilic Asthma Following a Switch from Omalizumab (OSMO Study): Asthma Control, Quality of Life and Lung Function Outcomes (2018) (4)
- Dupilumab Consistently Improves Rhinoconjunctivitis‐Specific Health‐Related Quality of Life in Patients With Uncontrolled, Moderate‐to‐Severe Asthma and Comorbid Allergic Rhinitis: Results from the Phase 3 LIBERTY ASTHMA QUEST Study: 304 (2019) (3)
- Therapeutic switch from omalizumab to mepolizumab in patients with uncontrolled severe eosinophilic asthma: treatment effect by prior omalizumab treatment duration: 307 (2019) (3)
- Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations (2018) (3)
- Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study. (2021) (3)
- A Multicenter, Randomized, Controlled Trial of Dexamethasone for Bronchiolitis (2008) (3)
- Biologics for Asthma and Allergic Skin Diseases in Children (2021) (3)
- A CYSTIC FIBROSIS MUTATION ASSOCIATED WITH MILD LUNG DISEASE (1996) (3)
- EFFECT OF OMALIZUMAB ON PERIPHERAL BLOOD EOSINOPHILS IN CHILDREN WITH MODERATE-SEVERE PERSISTENT ALLERGIC ASTHMA (2009) (3)
- A Physiologic Assessment of Segmental Bronchial Atresia1–3 (2015) (3)
- Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations. (2022) (3)
- Theophylline and the danger of differing absorption capabilities (1977) (3)
- Single bone involvement in congenital syphilis (1976) (3)
- Spontaneous resolution of multilobar atelectasis secondary to fibrinous mediastinitis. (1982) (3)
- Biologic Therapies of Immunologic Diseases. (2017) (3)
- Dupilumab Suppresses Type 2 Biomarkers in Asthma Patients With and Without Comorbid Chronic Rhinosinusitis With or Without Nasal Polyposis (CRS/NP): Post Hoc Analysis of LIBERTY ASTHMA QUEST: 296 (2019) (3)
- Fractional exhaled nitric oxide of at least 100 ppb and implications for future asthma research. (2014) (3)
- Determinants of lung function improvement with omalizumab in adults with allergic asthma. (2020) (3)
- A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF NEBULIZED EPINEPHRINE IN INFANTS WITH ACUTE BRONCHIOLITIS (2004) (3)
- Severe asthma exacerbation rates are increased among female, Black, Hispanic, and younger adult patients: results from the US CHRONICLE study (2022) (2)
- Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. (2010) (2)
- Update on the 2007 National Asthma Education and Prevention Program (2008) (2)
- Approach to the difficult pediatric asthmatic. (1999) (2)
- Renal involvement in systemic diseases in childhood. (1976) (2)
- Impact of Baseline IgE levels on Exacerbations and Asthma Symptom Control After Omalizumab Initiation (2018) (2)
- Response to Omalizumab Observed Over Wide Range of Blood Eosinophil Levels (2018) (2)
- Variability in asthma severity/control in pediatric asthma patients previously receiving short-acting beta2-agonists (2004) (2)
- To the editor: Reply to Dr. Bisgaard (2004) (2)
- Daily Versus As-Needed Corticosteroids for Mild Persistent Asthma (2006) (2)
- Managing chronic subdural hematomas and effusions in infants: a continuing dilemma. (1974) (2)
- Baseline characteristics of a large cohort of severe or difficult to treat asthma subjects from the epidemiology and natural history of asthma: Outcomes and treatment regimens (TENOR) study (2002) (2)
- A physiologic assessment of segmental bronchial atresia. (1980) (2)
- Dupilumab Efficacy in Patients with Uncontrolled or Oral Corticosteroid-Dependent Allergic and Non-allergic Asthma. (2022) (2)
- Chapter 6 – How Do You Diagnose Asthma in the Child? (2008) (2)
- EFFICACY OF ADDING NEBULIZED IPRATROPIUM BROMIDE TO NEBULIZED ALBUTEROL THERAPY IN ACUTE BRONCHIOLITIS (1994) (2)
- Decreased Exacerbations and Improvement in Asthma Symptom Control in Asthma COPD Overlap Treated With Omalizumab: Data From the Prospero Cohort Study (2017) (2)
- Allergy, Serum IgE, and Lung Function in Children and Adolescents With Severe or Difficult-to-Treat Asthma (2007) (2)
- Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects (2017) (2)
- Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects (2017) (2)
- Asthma as a Risk Factor for Invasive Pneumococcal Disease (2006) (2)
- Responder Analysis Evaluating the Long-term Treatment of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in Patients With Moderate to Severe Asthma With Versus Without Fixed Airflow Obstruction (FAO) (2013) (2)
- Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto Rico (2011) (1)
- Assessing the Asthma Impairment and Risk Questionnaire’s ability to predict exacerbations (2021) (1)
- Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections (2014) (1)
- Dose counting and use of short-acting beta-agonist inhalers in emergency department patients with asthma exacerbation. (2018) (1)
- Real-World Biologic Medication Use in a Diverse Population of US, Specialist-Treated Adults with Severe Asthma -Results of CHRONICLE Study (2019) (1)
- Stability of eosinophil classifications using common cut‐points over time: 28 (2019) (1)
- Efficacy of Budesonide/Formoterol Pressurized Metered-Dose Inhaler in Patients With Mild to Moderate Asthma With and Without Fixed Airflow Obstruction (2012) (1)
- P104 TOTAL NASAL SYMPTOM SCORE IMPROVEMENT WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, EOSINOPHILIC ASTHMA (2019) (1)
- Baseline Asthma Impairment and Risk Questionnaire (AIRQ™) Control Level is Associated with Future Risk of Exacerbations (2021) (1)
- 811 COURSE AND SEOUELAE OF H. INFLUENZAE B (HIB) EMPYEMA (1978) (1)
- Influence of Key Clinical Baseline Characteristics on Benralizumab Response for Patients with Severe, Uncontrolled Asthma and Moderate Blood Eosinophilia (2020) (1)
- Targeted interventions for difficult-to-treat asthma (2007) (1)
- Faculty of 1000 evaluation for Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. (2012) (1)
- Review of efficacy of ciclesonide for the treatment of asthma in children. (2021) (1)
- Demographic Characteristics, Comorbidities, and Exacerbation Frequency Among Patients Enrolled in the Chronicle Study: A Real‐World, Prospective, Observational Study of US, Subspecialist‐Treated Adults with Severe Asthma: L27 (2019) (1)
- MEDICAL PROGRESS OFFICE-BASED OBJECTIVE MEASURES IN CHILDHOOD ASTHMA (2006) (1)
- 692 VENOM IMMUNOTHERAPY FOR INSECT HYPERSENSITIVITY (1978) (1)
- THE EFFECT OF AGE ON BRONCHODILATOR RESPONSIVENESS (1994) (1)
- Diagnosis of Asthma in Preschool-Age Children (2014) (1)
- Characteristics by Provider Subspecialty of Patients Enrolled in the CHRONICLE Study: A Real-World, Prospective, Observational Study of US, Subspecialist-Treated Adults with Severe Asthma (2019) (1)
- Long-term outcomes from a pediatric subgroup of TENOR I: 10 years follow up (2017) (1)
- Montelukast, A Leukotriene-Receptor Antagonist, For the Treatmentof Mild Asthma and Exercise-Induced Bronchoconstriction (1999) (1)
- CHEMOSENSITIVITY AND PERCEPTION OF DYSPNEA IN PATIENTS WITH A HISTORY OF NEAR-FATAL ASTHMA (1995) (1)
- Carbon in Airway Macrophages and Lung Function in Children (2007) (1)
- Chronic cough: Watch for "red flags" (2015) (1)
- GENETIC SUSCEPTIBILITY TO ASTHMA— BRONCHIAL HYPERRESPONSIVENESS COINHERITED WITH MAJOR GENE FOR ATOPY (1996) (1)
- Skin testing and IgE levels in patients with severe or difficult-to-treat asthma (2005) (1)
- P062 BENRALIZUMAB REAL-WORLD EFFECTIVENESS ON EXACERBATIONS AMONG US SPECIALIST-TREATED PATIENTS WITH SEVERE ASTHMA: DATA FROM CHRONICLE (2021) (1)
- The Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQTM) and Health-Related Quality of Life (2020) (1)
- Safety of ciclesonide in children with asthma: A review of randomized controlled trials. (2021) (1)
- Clinically Significant Improvements in Asthma Patient-Reported Outcomes: Results from the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study (2017) (1)
- Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO. (2018) (1)
- Family History, Dust Mite Exposure in Early Childhood, and Risk for Pediatric Atopy and Asthma (2005) (1)
- Acute asthma: The basics of assessment and treatment (2002) (1)
- Evaluation of the Impairment Domain Components of the NHLBI Guidelines in Classifying Asthma Control and Predicting Future Asthma Exacerbations (2010) (1)
- Characteristics of US, Subspecialist-Treated Adults with Severe Asthma Receiving and Not Receiving Therapy with Biologic Medications in the CHRONICLE Study (2019) (1)
- Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the TENOR-II Cohort. (2021) (1)
- The Bela Schick Lecture: if you don't know where you are going, you may end up somewhere else. (2015) (1)
- P235 Budgetary impact model on a medicare plan adopting short-acting beta-agonist inhalers with integrated dose counters (2017) (0)
- From the Pages of Allergy Watch. (2020) (0)
- A PROSPECTIVE RANDOMIZED STUDY OF CONTINUOUS VERSUS INTERMITTENT NEBULIZED ALBUTEROL FOR SEVERE STATUS ASTHMATICUS IN CHILDREN (1995) (0)
- P230 Long-term assessment of the burden of atopic sensitization in patients with severe/difficult-to-treat asthma (2017) (0)
- Feasibility of Using Treatment Response Thresholds for Lung Function and Asthma Symptom Variables As Indicators of Asthma Control in Patients with Moderate to Severe Asthma (2016) (0)
- Noninvasive evaluation in cystic fibrosis of ventricular function (1979) (0)
- EFFECTS OF OMALIZUMAB ON MARKERS OF TYPE 2 INFLAMMATION: RESULTS FROM THE EXTRA STUDY (2018) (0)
- Effects of Budesonide/Formoterol (BUD/FM) Deliverd By Pressurized Metered-Dose Inhaler (pMDI) on Symptoms In African Americans and Caucasians With Moderate and Severe Asthma With and Without Fixed Airway Obstruction (FAO) (2014) (0)
- Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma (SEA): Subgroup Analyses of Patients Using Maintenance Oral Corticosteroids (OCS) Prior to Treatment Initiation (2020) (0)
- An Analysis of Type 2 Biomarkers in TENOR II (2018) (0)
- CONFIRMATORY CROSS-SECTIONAL VALIDATION OF THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) (2020) (0)
- Phenotypes Determined By Cluster Analysis In Patients With Severe Or Difficult-To-Treat Asthma In The TENOR Cohort (2012) (0)
- NOT RUNNING ON EMPTY (2006) (0)
- Demographic Characteristics and Laboratory Biomarker Testing of Patients Receiving Individual Biologic Therapies for Severe Asthma in the United States (2021) (0)
- From the Pages of Allergy Watch: December 2019. (2019) (0)
- Health-related Quality of Life and Productivity Among a Real-World Cohort of Severe Asthma Patients in the United States (2020) (0)
- BIOLOGIC MEDICATIONS FOR SEVERE ASTHMA ARE EFFECTIVE IN THE REAL-WORLD, INCLUDING IN SUBGROUPS NOT STUDIED IN RANDOMIZED TRIALS (2021) (0)
- Do Fish Oil Supplements During Pregnancy Prevent Asthma ? (2018) (0)
- Recent advances in asthma. (2018) (0)
- Asthma Control and Risk of Future Asthma Exacerbations: Evaluation of the Impairment Domain of the NHLBI Guidelines in the TENOR Cohort (2009) (0)
- P205 SWITCH FROM OMALIZUMAB TO MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA: EFFECT OF WEIGHT AND BMI (2020) (0)
- Inhaled nitric oxide for acute asthma. Authors' reply (2006) (0)
- Faculty Opinions recommendation of Daily or intermittent budesonide in preschool children with recurrent wheezing. (2011) (0)
- Effects Of Long-Term Treatment With Budesonide/Formoterol (BUD/FM) Delivered By Pressurized Metered-Dose Inhaler (pMDI) On Symptoms In African-American and Caucasian Patients With Moderate To Severe Asthma With and Without Fixed Airway Obstruction (FAO) (2014) (0)
- Continuous Intravenous Terbutaline for Pediatric StatusAsthmaticus (1999) (0)
- Asthma Yardstick (2017) (0)
- TENOR Study Difficult-to-Treat Asthma: Insights From the Airflow Limitation in Severe or Risk Factors Associated With Persistent (2007) (0)
- P224 REAL-WORLD EVIDENCE OF IMPROVED PATIENT OUTCOMES WITH RESLIZUMAB IN ADULTS WITH SEVERE EOSINOPHILIC ASTHMA (SEA) (2019) (0)
- Post Hoc Analysis of a Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) Study: Asthma Control and Study Withdrawal in Patients With Mild to Moderate Asthma With Versus Without Fixed Airflow Obstruction Defined Using 2 Different Criteria (2012) (0)
- PREDICTORS OF A FUTURE SEVERE ASTHMA EXACERBATION AFTER A DECADE FOLLOW-UP: RESULTS FROM TENOR II (2018) (0)
- Dupilumab in Children With Uncontrolled Moderate-to-Severe Asthma (2022) (0)
- Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. Reply. (2022) (0)
- A Comparison of Active and Simulated Chiropractic Manipulation asAdjunctive Treatment for Childhood Asthma (1999) (0)
- Differing perceptions of asthma control and treatment effectiveness by patients with severe asthma and treating subspecialists in the United States (2021) (0)
- Faculty Opinions recommendation of Decision making in patients with pulmonary nodules. (2012) (0)
- Faculty Opinions recommendation of Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. (2012) (0)
- APPLICATION OF ORAL IMMUNOTHERAPY (OIT) CLINICAL TRIAL ENDPOINTS TO A REAL-WORLD SETTING (2018) (0)
- Zileuton for the Prophylaxis and Chronic Treatment of Asthma (2008) (0)
- From the pages of AllergyWatch®: February 2021. (2020) (0)
- Pediatric Dilemmas: Allergy and Beyond (2013) (0)
- Evaluating Performance of the Asthma Impairment and Risk Questionnaire (AIRQ™) in Primary and Specialty Care (2021) (0)
- Effect of Reversibility and Eosinophils on Lung Function Improvement with Omalizumab Treatment: Pooled Analyses in Patients with Moderate or Severe Allergic Asthma (2019) (0)
- Detectionof PulmonaryAspirationin InfantsandChildrenwith Respiratory Disease:ConciseCommunication (2006) (0)
- Responder Analysis Evaluating the Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in Patients with Moderate to Severe Asthma with Versus without Fixed Airflow Obstruction (FAO) (2013) (0)
- that will be most beneficial. Further studies would benefit from a larger sample, more precise characterization of asthma (to rule out other illnesses that can cause elevated FeNO levels, such as eosin- ophilic bronchitis), and an assessment of medication adherence. (2014) (0)
- P060 ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) AT BASELINE PREDICTS 12-MONTH HEALTH-RELATED QUALITY OF LIFE (HRQOL) (2021) (0)
- Preferences in terminology used to describe oral immunotherapy varies based on physician utilization (2020) (0)
- REPRODUCIBILITY OF THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) (2021) (0)
- From pages of Allergy Watch: April-2020. (2019) (0)
- From the Pages of Allergy Watch. (2020) (0)
- Novel epinephrine auto-injector (NEA): sharps injury prevention validation and comparable analysis with EpiPen and Twinject. (2011) (0)
- Real-World Evidence of Reductions in Health Resource Utilization (HRU) and Improved Efficacy Outcomes Associated with Reslizumab Treatment in Adults with Severe Eosinophilic Asthma (SEA) in the United States (2020) (0)
- Clinical Features and Anaphylaxis in Children With Cold Urticaria (2005) (0)
- Faculty Opinions recommendation of Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. (2012) (0)
- Association Between Severity of Asthma Exacerbations and Asthma-Related Quality of Life in Patients With Severe or Difficult-to-Treat Asthm (2011) (0)
- Do Weather Conditions Asthmatics Change Pulmonary Function of at Summer Camp (1984) (0)
- Long-term Effects of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in African-American Patients With Moderate to Severe Asthma: Responder Analysis in Patients With Versus Without Fixed Airflow Obstruction (FAO) (2013) (0)
- From the Pages of AllergyWatch. (2022) (0)
- In the UnitedStates,wesupportthe approachrecommended by the US Rhinitis Practice Parameters, which recommends NAH as first-line therapy. 2 It is our unanimous clinical experience that these medications are useful as a primary therapy. (2016) (0)
- Clinical characteristics and disease control of US asthma patients treated in specialty clinics (2020) (0)
- Biomarkers Associated with Response in Patients Initiating Omalizumab: Baseline Levels Among Patients in the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study (2016) (0)
- Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma. (2023) (0)
- Are Inhaled Corticosteroids and Inhaled Corticosteroids/Long-acting β-Agonist of Use in Acute Asthma: an Update on Evidence (2019) (0)
- Poster 74: A Multisite Patient Perception Study of Olopatadine 0.2% Compared To Epinastine 0.05% in Patients With Allergic Conjunctivitis (2008) (0)
- Real-world Evidence of Improved Patient Outcomes With Reslizumab in Non-exacerbating Patients With Severe Eosinophilic Asthma (SEA): A Subgroup Analysis (2020) (0)
- Lessons learned from the epidemiology and natural history of asthma: Outcomes and treatment regimens (TENOR) (2011) (0)
- O018 Asthma exacerbations and triggers in children with severe/difficult-to-treat asthma: Impact on quality of life (2016) (0)
- Phase III Evaluation of the Efficacy and Safety of PT027 (Budesonide/Albuterol pMDI) Compared to Placebo pMDI on Exercise-Induced Bronchoconstriction in Adult and Adolescent Subjects with Asthma: the TYREE Study (0)
- From the Pages of Allergy Watch. (2021) (0)
- P208 Contribution of obesity to disease burden in children with severe or difficult-to-treat asthma (2017) (0)
- Recent advances in our understanding of the environment's role in allergy. (2018) (0)
- P223 EVALUATING PERFORMANCE OF THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ™) AT 3-MONTH INTERVALS (2020) (0)
- Anaphylaxis: A 7-Year Follow-up Survey of 46 Children (2005) (0)
- EDS-FLU (EXHALATION DELIVERY SYSTEM WITH FLUTICASONE) BENEFITS ON NASAL POLYP DISEASE RELATIVE TO MONOCLONAL ANTIBODIES (2018) (0)
- Identifying Patients for Self-Administration of Omalizumab (2022) (0)
- From the Pages of Allergy Watch. (2021) (0)
- in Pediatric Practices Longitudinal Validation of the Test for Respiratory and Asthma Control in Kids (2011) (0)
- P120 Burden of severe or poorly-controlled asthma in school-age children: healthcare use and allergic co-morbidities (2016) (0)
- Correction to: Identifying Patients for Self-Administration of Omalizumab (2022) (0)
- High medication usage in a large cohort of patients with severe or difficult-to-treat asthma* (2003) (0)
- From the Pages of AllergyWatch. (2022) (0)
- From the pages of AllergyWatch September 2021 (0)
- Efficacy and Safety of Itepekimab in Patients With Moderate-to-Severe Asthma (2022) (0)
- From the pages of AllergyWatch. (2020) (0)
- Poster Session4200Monday, March 21, 20059:45 AM to 10:45 AMVariability in asthma severity in pediatric asthma patients previously receiving short-acting beta2-agonists (2005) (0)
- From the Pages of AllergyWatch. (2022) (0)
- Continuous Positive Airway Pressure in Hemidiaphragmatic Paralysis (1981) (0)
- Maintenance Systemic Corticosteroid Use Is Associated with Multiple Adverse Conditions in U.S. Adults with Severe Asthma: Results from the Chronicle Study (2020) (0)
- Effects of Doubling the Highest Indicated Dose of Budesonide/Formoterol (BUD/FM) on Lung Function and Symptoms in Moderate-to-Severe Asthma with Fixed Airflow Obstruction (FAO) (2015) (0)
- Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma (2022) (0)
- Therapeutic switch from omalizumab to mepolizumab in patients with uncontrolled severe eosinophilic asthma: treatment effect by exacerbations in previous year and maintenance use of OCS (2020) (0)
- P065 DISEASE TRIGGERS AND ASSOCIATED QUALITY OF LIFE AMONG SPECIALIST-TREATED US PATIENTS WITH SEVERE ASTHMA (2021) (0)
- P236 Comorbidities associated with poor short-acting beta-agonist inhaler handling among united states respiratory patients (2017) (0)
- Not running on empty. Auhtors' reply (2006) (0)
- Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the Tenor II Cohort (2016) (0)
- From the Pages of Allergy Watch. (2020) (0)
- Preferences in Terminology Used to Describe Oral Immunotherapy Varies Based on Physician Utilization: 810 (2019) (0)
- BIOLOGIC MEDICATION USE AND SWITCHING AMONG REAL-WORLD, SPECIALIST-TREATED ADULTS WITH SEVERE ASTHMA: RESULTS OF THE CHRONICLE STUDY (2020) (0)
- Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence (2023) (0)
- Assessment of asthma morbidity by US patients, specialists, Asthma Control Test™, and Asthma Impairment and Risk Questionnaire™ (2020) (0)
- Asthma Control and Study Withdrawal in Patients With Versus Without Fixed Airflow Obstruction (2 Criteria): Post Hoc Analysis of a Budesonide/Formoterol Pressurized Metered-Dose Inhaler Study in Patients With Moderate to Severe Asthma (2012) (0)
- SIGNIFICANT IMPROVEMENT IN LUNG FUNCTION FOLLOWING 16 WEEKS OF OMALIZUMAB TREATMENT: POOLED ANALYSES IN PATIENTS WITH MODERATE-TO-SEVERE ALLERGIC ASTHMA (2018) (0)
- CLASSIFICATION OF ASTHMA SEVERITY AMONG STEROID-NAÏVE PEDIATRIC SUBJECTS PREVIOUSLY RECEIVING SHORT-ACTING BETA2-AGONISTS: DO THE GUIDELINES NEED REVISITING? (2005) (0)
- From the Pages of AllergyWatch. (2022) (0)
- Effect of Fixed Airflow Obstruction (FAO) Status on Lung Function, Asthma Control Days (ACD), and Asthma Symptom Score (AS) Responses to Budesonide/Formoterol (BUD/FM) Treatment in Patients with Moderate-to-Severe Asthma (2015) (0)
- Environmental factors theophylline level and pulmonary function in asthmatics (1979) (0)
- How Do Rates of Asthma Exacerbations Compare in Pediatric and Adult Patients in TENOR (2009) (0)
- Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in African-American Patients with Moderate to Severe Asthma: Responder Analysis in Patients with Versus without Fixed Airflow Obstruction (FAO) (2013) (0)
- From the pages of AllergyWatch® (2021) (0)
- COMPARISON OF ASTHMA CONTROL AND TREATMENT EFFECTIVENESS ASSESSMENTS BETWEEN US PATIENTS WITH ASTHMA AND TREATING SUBSPECIALISTS: REAL-WORLD DATA FROM THE CHRONICLE STUDY (2019) (0)
- Spirometry versus flow volume inspiratory and expiratory loop. (2011) (0)
- DOES ASTHMA OR TREATMENT WITH THEOPHYLLINE LIMIT CHILDREN'S ACADEMIC PERFORMANCE? (1994) (0)
- From the pages of AllergyWatch®: November 2020. (2020) (0)
- Expert Advice on Managing Severe Asthma: An Interactive Decision Support Tool Provides Real-Time Expert Recommendations (2021) (0)
- Acute asthma. (1986) (0)
- P204 FACTORS ASSOCIATED WITH BIOLOGIC OR MAINTENANCE SYSTEMIC CORTICOSTEROID TREATMENT AMONG UNITED STATES SEVERE ASTHMA PATIENTS (2019) (0)
- A Synopsis of the Synopses (2007) (0)
- Research abstracts presented at the Western Society of Allergy, Asthma, and Immunology Meeting, January 24‐28, 2010 (2010) (0)
- Asthma & Other Lung Diseases/Allergy Testing & Therapeutics/Rhinosinusitis/Ocular Allergy (2018) (0)
- From Pages of Allergy Watch-March 2020. (2019) (0)
- P146 Influence of inhalation technique on lung deposition using flunisolide HFA, fluticasone HFA and beclomethasone HFA (2016) (0)
- Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists. (2022) (0)
- RESPONSE TO OMALIZUMAB TREATMENT IN PATIENTS WITH FIXED AIRFLOW OBSTRUCTION (2019) (0)
- Helen Skolnick SPECIALTY CARE KNOWLEDGE AND PRACTICE OF DUST MITE CONTROL BY Services (0)
- Determinants of Lung Function Decline in Children and Adolescents With Severe Asthma (2017) (0)
- Management of acute bronchospasm in pediatric populations. (2005) (0)
- Reply. (2019) (0)
- Effects of Sex and Age on Characteristics of United States Patients With Severe Asthma (2021) (0)
- Reply to Dr. Bisgaard. (2004) (0)
- Control your child's asthma. By Harold Farber. Henry Holt, 2000, 231 pp. (2002) (0)
- Section on Allergy and Immunology (2007) (0)
- The Association Of Exacerbations With Quality Of Life In Children With Severe-or-Difficult To Treat Asthma (2010) (0)
- ACCURACY OF MINI PEAK-FLOW METERS (PFMS) IN INDICATING CHANGES IN LUNG FUNCTION IN CHILDREN WITH ASTHMA (1995) (0)
- ATTITUDES AMONG U.S.-BASED ALLERGISTS AND IMMUNOLOGISTS ABOUT IMMUNOTHERAPY, PEANUT EXPOSURE AND TREATMENT (2018) (0)
- Effect Of Fixed Airflow Obstruction On Response To Budesonide/Formoterol Pressurized Metered-Dose Inhaler Treatment In African-American Adolescents And Adults With Moderate To Severe Asthma (2012) (0)
- O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab (2016) (0)
- The Evolution of Childhood Wheezing to Asthma (2014) (0)
- From the Pages of Allergy Watch. (2021) (0)
- Albuterol-budesonide pressurized metered dose inhaler in patients with mild-to-moderate asthma: results of the DENALI double-blind randomized controlled trial. (2023) (0)
- Effect Of Budesonide/Formoterol Pressurized Metered-Dose Inhaler On Pulmonary Function In Hispanic Adolescents And Adults With Moderate To Severe Asthma With Or Without Fixed Airflow Obstruction (2012) (0)
- Treatment Response To Omalizumab And Reduced Asthma Exacerbations And Asthma-Related Healthcare Resource Use From The Real-World PROSPERO Study (2020) (0)
- Therapeutic Switch from Omalizumab to Mepolizumab in Patients with Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by ACQ and SGRQ Quartiles (2020) (0)
- From the Pages of Allergy Watch. (2021) (0)
- Are PPIs beneficial for nasal polyps? (2019) (0)
- Faculty Opinions recommendation of Abnormal vocal cord function in difficult-to-treat asthma. (2011) (0)
- Treatment of Acute Asthma (2011) (0)
- From the Pages of Allergy Watch. (2022) (0)
- Baseline Characteristics Associated with Quartiles of Reslizumab Effect: Pooled Analysis Of Two Phase 3 Studies (2018) (0)
- Oral Corticosteroid Use and Health Outcomes in Patients with Severe or Difficult-to-Treat Asthma (2015) (0)
- Asthma Diagnosis and Biomarkers (2016) (0)
- Biologics for Asthma and Allergic Skin Diseases in Children. (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bradley E. Chipps?
Bradley E. Chipps is affiliated with the following schools: